Rachel Haurwitz, Ph.D.

Rachel Haurwitz, Ph.D.

Co-founder, President and CEO, Caribou Biosciences

Rachel is co-founder, president, and CEO of Caribou Biosciences, a CRISPR gene editing company developing cellular therapies to treat cancer. In 2014, she was named by Forbes Magazine to the “30 Under 30” list in Science and Healthcare, and in 2016, Fortune Magazine named her to the “40 Under 40” list of the most influential young people in business. In 2018, the Association for Women in Science recognized Rachel with the annual Next Generation Award. Rachel earned an A.B. in Biological Sciences from Harvard College, and received a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.